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 This pilot study of 28 patients demonstrated a significant difference in utility value derived from the Standard Gamble and 
the generic health-related quality of life instruments
 There were 21 patients with stress urinary incontinence, 6 patients with urge urinary incontinence and 1 patient with 
mixed urinary incontinence
 Mean Sandvik score was higher in Urge Incontinence subgroup
 Mean Utility from Standard Gamble was lower in Urge Incontinence group
 Sandvik scores were moderately correlated with EQ-5D, SG and VAS utilities
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 Utility scores derived from Standard Gamble were significantly higher than those derived from 
generic health related quality of life instruments.
 Utility scores derived from EQ-5D and VAS were similar to those  previously reported in the 
literature. [6,7]
 Current utility values over-estimate the degree of bother of urinary incontinence.
 Researchers should consider using higher utility values for urinary incontinence in future cost 
utility and quality of life studies.
The goal of this study was to define the utility of urinary incontinence in 
women using the Standard Gamble, the gold standard method for 
determining health state utilities, based on a diagnosis obtained from 
multichannel urodynamic testing, the gold standard in clinical diagnosis.
Health state utility values are important in many areas of medical 
research.  The values are used in cost-utility analysis, decision analysis 
and health related quality of life studies.  To date, studies that have 
estimated the utility of urinary incontinence in women have relied on 
values from generic health related quality of life questionnaires such as 
the ED-5Q and Health Utilities Index or from expert opinion. [1-5]  The 
utility of urinary incontinence in these studies appears to be 
unintuitively low, at 0.71 to 0.82, with perfect health represented by 1.0. 
[6, 7]  The utility of health states that are much more debilitating, for 
example cancer (0.82), is higher than urinary incontinence. [6]
These studies have relied on patient self-diagnosis of incontinence.  
Additionally, they have considered all types of urinary incontinence 
together.  Intuitively, one would think that quality of life would be 
affected differently with different types (stress, urge, mixed) and 
differing severity of incontinence.
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 All adult female patients who underwent urodynamic testing at 
Brigham and Women’s Hospital were prospectively recruited
 Diagnosis of type of incontinence was made by attending physician 
interpretation of the urodynamic study
 No exclusion criteria
 Patients completed three validated questionnaires
1. Sandvik Severity Index
A validated two question symptom specific instrument to evaluate
urinary incontinence
2. EQ-5D
 A five-domain generic quality of life questionnaire
 Answers are converted into a utility value 
3. Visual Analog Scale
 Vertical line from 0 (worst imaginable health) to 100 (best 
imaginable health) 
 Patient rates own perception of health on line
 The Standard Gamble technique was used in a standard format to 
determine each patient’s utility value for their health state
 Patient is asked to choose between life in current health state 
and varying risks of immediate painless death
 Gold Standard method to determine patients utility 
preference for their health state
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Fig 2.  Stress Incontinence Utilities
Combined Group Stress Incontinence Urge Incontinence
Age (y) 55.5 + 15.8 58.9 + 12.9 42.0 + 25.5
BMI (kg/m2) 29.3 + 7.9 29.3 + 8.4 29.2 + 8.3
Menopause 70 % 50% 75%
Sandvik 8 + 3 7 + 3 12 + 0
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Fig 1.  Urinary Incontinence Utilities
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